Back to BlackRock, Inc. BlackRock, Inc.

GALTGALT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in GALECTIN THERAPEUTICS INC

BlackRock, Inc. holds 3M shares of GALT (GALECTIN THERAPEUTICS INC), worth $13.9M as of 2026-Q2. The position was increased (+273.9% shares). GALT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$13.9M

Current Shares

3M

Total Value Change

+$11.7M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3M
+273.9%
$13.9M0.0%$4.64
45
2026-Q1
Increased
799,237
+0.3%
$2.2M0.0%$2.98
18
2025-Q4
Decreased
796,558
-0.1%
$3.3M0.0%$4.08
0
2025-Q3
Decreased
797,669
-10.6%
$3.4M0.0%$4.22
0
2025-Q2
Decreased
891,879
-37.0%
$1.9M0.0%$2.33
0
2025-Q1
Decreased
1.4M
-14.3%
$1.7M0.0%$1.52
0
2024-Q4
New
1.7M
-
$2.1M0.0%$1.10
40

Other major holders of GALT: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, OSAIC HOLDINGS, INC., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used